Literature DB >> 24234001

Fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artifactual result of research methodology?

Basile Njei.   

Abstract

Entities:  

Keywords:  CARCINOGENESIS; EPIDEMIOLOGY

Mesh：

Year:  2013        PMID： 24234001     DOI： 10.1136/gutjnl-2013-306333

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  2 in total

1.  Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients.

Authors:  Jiawei Hu; Yi Wang; Liming Deng; Haitao Yu; Kaiyu Chen; Wenming Bao; Kaiwen Chen; Gang Chen
Journal:  Updates Surg       Date:  2022-06-17

2.  Progression after Immunotherapy for Fibrolamellar Carcinoma.

Authors:  Ulrike Bauer; Carolin Mogler; Rickmer F Braren; Hana Algül; Roland M Schmid; Ursula Ehmer
Journal:  Visc Med       Date:  2019-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.